functional dyspepsia
Conditions
Interventions
Queue 1 (Biling Weitong Granules):None
Queue 2 (proton pump inhibitor):None
Queue 3 (Biling Weitong Granules+proton pump inhibitor):None
Sponsors
Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Patients who meet the diagnostic criteria for functional dyspepsia EPS or have PDS with overlapping EPS; 2. Age range from 18 to 75 years old, regardless of gender; 3. Middle and upper abdominal pain or burning discomfort in the middle and upper abdomen shall be evaluated using a 5-level Likert scale score (0 points for asymptomatic symptoms, 4 points for obvious symptoms that seriously affect work and life), with an average score of = 2 points for any item in the past 1 week (calculation method of average score: the total score of the past 1 week duration divided by the number of days with symptoms); 4. Voluntarily sign an informed consent form to participate in this study.
Exclusion criteria
Exclusion criteria: 1.Reflux esophagitis (LA-B grade or above), active peptic ulcers, malignant tumors of the upper digestive tract, and other organic diseases that may cause discomfort or burning sensation in the upper middle abdomen; 2. Severe heart, brain, liver, lung, kidney, tumor and other diseases; 3. Those who have participated in other clinical research trials within the past 3 months; 4. Other factors that the researcher believes are not suitable for enrollment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical efficacy rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical effectiveness of each visit point;Frequency of discomfort caused by upper abdominal pain and burning;Rate/time of disappearance of upper abdominal pain and burning discomfort;Efficacy of other symptoms in FD;Functional Gastrointestinal Disease Quality of Life Scale Score;Traditional Chinese Medicine Syndrome Curative Effect;Consumption of Hydrotalcite Tablets;Satisfaction score of treatment efficacy;Incidence of adverse events/reactions; | — |
Countries
China
Contacts
Public Contactfangxiucai
Peking Union Medical College Hospital
Outcome results
None listed